整合素:心肌病精准医疗的新靶标?

邹云增; 张潇伊; 龚惠

doi:10.13201/j.issn.1001-1439.2016.08.001

整合素:心肌病精准医疗的新靶标?

- 复旦大学附属中山医院心内科(上海, 200032)

详细信息

通讯作者: 邹云增,E-mail:yunzengzou1024@aliyun.com

中图分类号: R542.2

收稿日期: 2016-07-05

Integrin:a new target for precision medicine of cardiomyopathy?

- Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China

More Information

Corresponding author: ZOU Yun-zeng, E-mail: yunzengzou1024@aliyun.com

Received Date: 05 July 2016

摘要

摘要: 心肌病通常与遗传有关,常由单个心肌蛋白突变造成。精准诊治目前是心肌病面临的困境。整合素在心肌细胞机械刺激的传导和感应中起到主要作用。整合素和一些相关的细胞骨架蛋白,能将肌动蛋白同细胞外基质联系起来,并触发细胞内信号途径,引起心肌肥大。本文通过对整合素致心肌肥大机制的深入认识,揭示心肌病精准医疗的新靶标。
- 心肌病 /
- 心肌肥大 /
- 整合素 /
- 精准医疗
Abstract: Cardiomyopathy is usually associated with genetic mutations,which caused by the single mutation in cardiac protein.Precision diagnosis and treatment of cardiomyopathy are difficult at present.Integrin plays an important role in the conduction and induction of mechanical stimulation in cardiomyocytes.Integrin and a number of related cytoskeletal proteins,can link to actin and extracellular matrix,and trigger the intracellular signaling pathway,which causes cardiac hypertrophy.In this paper,we explore the mechanism about cardiac hypertrophy induced by integrin,and reveal the new target of the precise medical treatment in cardiomyopathy.
- cardiomyopathy /
- cardiac hypertrophy /
- integrin /
- precision medicine

HTML全文

参考文献(23)

[1]	HUMPHRIES M J.Integrin structure[J].Biochem Soc Trans,2000,28:311-339.
[2]	HYNES R O.Cell adhesion:old and new questions[J].Trends Cell Biol,1999,9:M33-37.
[3]	SIMPSON D G,TERRACIO L.Modulation of cardiac myocyte phenotype in vitro by the composition and orientation of the extracellular matrix[J].J Cell Physiol,1994,161:89-105.
[4]	SHAI S Y,HARPF A E.Cardiac myocyte-specific excision of the beta1 integrin gene results in myocardial fibrosis and cardiac failure[J].Circ Res,2002,90:458-464.
[5]	KELLER R S,SHAI S Y.Disruption of integrin function in the murine myocardium leads to perinatal lethality,fibrosis,and abnormal cardiac performance[J].Am J Pathol,2001,158:1079-1090.
[6]	ROSS R S,BORG T K.Integrins and the myocardium[J].Circ Res,2001,88:1112-1119.
[7]	JIE REN,JOAN AVERY,.Muslin.β3 Integrin deficiency promotes cardiac hypertrophy and inflammation[J].J Mol Cel Cardiol,2007,42:367-377.
[8]	GEETHA SURYAKUMAR,HARINATH KASIGANESAN.Lack of b3 Integrin Signaling Contributes to Calpain-Mediated Myocardial Cell Loss in Pressure-Overloaded Myocardium[J].J Cardiovasc Pharmacol,2010,55:567-573.
[9]	BALASUBRAMANIAN S,QUINONES L,KASIGANESAN H,et al.β3 integrin in cardiac fibroblast is critical for extracellular matrix accumulation during pressure overload hypertrophy in mouse[J].PLoS One,2012,7:e45076.
[10]	LAFLAMME S E,HOMAN S M.Integrin cytoplasmic domains as connectors to the cell's signal transduction apparatus[J].Matrix Biol,1997,16:153-163.
[11]	MITRA S K,HANSON D A.Focal adhesion kinase:in command and control of cell motility[J].Nat Rev Mol Cell Biol,2005,6:56-68.
[12]	HEIDKAMP M C,BAYER A L.GFPFRNK disrupts focal adhesions and induces anoikis in neonatal rat ventricular myocytes[J].Circ Res,2002,90:1282-1289.
[13]	BRANCACCIO M,GUAZZONE S.Melusin is a new muscle-specific interactor for beta(1)integrin cytoplasmic domain[J].J Biol Chem,1999,274:29282-29288.
[14]	DE ACETIS M,NOTTE A.Cardiac overexpression of melusin protects from dilated cardiomyopathy due to long-standing pressure overload[J].Circ Res,2005,96:1087-1094.
[15]	DORN II G W,FORCE T.Protein kinase cascades in the regulation of cardiac hypertrophy[J].J Clin Invest,2005,115:527-537.
[16]	CECI M,ROSS JR J,CONDORELLI G.Molecular determinants of the physiological adaptation to stress in the cardiomyocyte:a focus on AKT[J].J Mol Cell Cardiol,2004,37:905-912.
[17]	WHITE D E,COUTU P.Targeted ablation of ILK from the murine heart results in dilated cardiomyopa2 thy and spontaneous heart failure[J].Genes Dev,2006,20:2355-2360.
[18]	MAEDA M,HOLDER E.Dilated cardiomyopathy associated with deficiency of the cytoskeletal protein metavinculin[J].Circulation,1997,95:17-20.
[19]	MARIAN A J.Modifier genes for hypertrophic cardiomyopathy[J].Curr Opin Cardiol,2002,17:242-252.
[20]	KRAUSE M,DENT E W.Ena/VASP proteins:regulators of the actin cytoskeleton and cell migration[J].Annu Rev Cell Dev Biol,2003,19:541-564.
[21]	EIGENTHALER M,ENGELHARDT S.Disruption of cardiac Ena-VASP protein localization in intercalated disks causes dilated cardiomyopathy[J].Am J Physiol Heart Circ Physiol,2003,285:H2471-2481.
[22]	THOMPSON J T,RACKLEY M S,O'BRIEN T X.Upregulation of the cardiac homeobox gene Nkx2-5(CSX)in feline right ventricular pressure overload[J].Am J Physiol,1998,274:H1569-1573.
[23]	邹云增,杨茗.Ⅱ型糖尿病合并冠心病的机制[J].临床心血管病杂志,2015,31(4):366-369.